APA (7th ed.) Citation

Abbasifard, M., Dehghan Banadaki, M., Taghipour Khaje Sharifi, G., Rahnama, A., & Bagheri-Hosseinabadi, Z. (2024). Serum Dehydroepiandrosterone sulfate (DHEA-S) level and its potential impact on immune responses and symptom severity after Oxford-AstraZeneca COVID-19 vaccination. International immunopharmacology, 133, 112057. https://doi.org/10.1016/j.intimp.2024.112057

Chicago Style (17th ed.) Citation

Abbasifard, Mitra, Maryam Dehghan Banadaki, Gholamhossein Taghipour Khaje Sharifi, Amir Rahnama, and Zahra Bagheri-Hosseinabadi. "Serum Dehydroepiandrosterone Sulfate (DHEA-S) Level and Its Potential Impact on Immune Responses and Symptom Severity After Oxford-AstraZeneca COVID-19 Vaccination." International Immunopharmacology 133 (2024): 112057. https://doi.org/10.1016/j.intimp.2024.112057.

MLA (9th ed.) Citation

Abbasifard, Mitra, et al. "Serum Dehydroepiandrosterone Sulfate (DHEA-S) Level and Its Potential Impact on Immune Responses and Symptom Severity After Oxford-AstraZeneca COVID-19 Vaccination." International Immunopharmacology, vol. 133, 2024, p. 112057, https://doi.org/10.1016/j.intimp.2024.112057.